Salesforce (CRM)

Software / Servicios de aplicaciones

The leader in customer relationship management (CRM) software, punished in the market by fear of AI disruption and confusion over its reported growth. Net of stock-based compensation and the ASR debt, it trades at ~19× owner-FCF — the cheap end of quality software. Base case 5y ~$308 (+6%/year): Fairly valued — the moat (switching costs + a $72bn contracted backlog) and the compounding cash flow are undervalued, even though the new leverage and the AI threat are real.

Moat Compounder estimates the intrinsic value of Salesforce (CRM) at $308 per share on a five-year horizon. With the stock at $233.92 at 2026-10-12 close, the expected total return is 6.5% per year: fairly valued. The analysis draws on 10-K FY2026 and 10-Q Q1 FY2027. Analysis dated 2026-08-27.

Price
$233.92
at 2026-10-12 close
Intrinsic value (5y, base)
$308
Total annual return (5y)
6.5%
5.7% price · 0.8% div
Status (nominal)
Fairly valued
Margin of safety
+9%

The essentials

  • The undisputed leader in customer relationship management (CRM) software: revenue $42.8bn, 95% recurring subscription, with a contracted backlog (RPO) of $72.4bn (+14%) and a cRPO accelerating faster than revenue. Margins expanding sharply (GAAP operating margin 3.3%→20.1% over 4 years, non-GAAP 22.5%→34.1%) with ValueAct's activism pushing the discipline.
  • Trades at 19× owner free cash flow — the market treats it as a mature, no-growth SaaS, punished by fear that AI will cannibalize seats and by confusion over its reported growth (two product taxonomy redesigns in 6 months + the noise from Informatica).
  • ⚠️ The capital structure changed abruptly: in March 2026 it issued $25bn of debt to fund an accelerated share repurchase (ASR) — shares fell from ~923M to ~819M in one quarter, but debt jumped to $39.3bn (net debt ~$27.9bn) and cash flow guidance was cut for the interest cost. The 'cheap P/FCF' is doubly misleading: FCF adds back stock-based compensation (~24% of the flow) and the price ignores net debt. The real metric, EV/owner-FCF net of both, is ~19×.
Source 10-K FY2026 Jan-31-2026 ·10-Q Q1 FY2027 Apr-30-2026 ·DEF 14A 2026 (proxy) Apr-16-2026 ·8-K Q2 FY2027 results Aug 26, 2026
Health: Under watch
Price $234 at 2026-10-12 closeMarket Cap $191.6 bnEnterprise Value $219.5 bnNet debt $27.9 bnEV/owner-FCF (ex-SBC) (today) 19.1x

Intrinsic value — two valuation methods

Fairly valued
Price market
$234
DCF value today
$411
+75.7% vs price
Multiples value today
$256
+9.6% vs price

Total return at 5 years: 6.5%/year = 5.7% appreciation + 0.8% dividend. The target price ($308) is ex-dividend; the $11 in dividends collected over 5 years are added separately.

By both methods, the value today (DCF $411 · Multiples $256) exceeds the market price ($234).

Pillars of the analysis

The verdict — today vs 5 years

Today — fairly valued: at $234 trades ~8.7% below its value discounted to today (~$256); the discount is positive but does not reach the margin of safety we require (≥38%).

At 5 years — En valor: the target price ($308) plus dividends yield between the 4% floor and the 10% average return — a reasonable return, though without the margin of a great investment.

The bridge: the return at 5 years exceeds the risk-free rate (4.5%) — but the discount does not reach the required margin of safety (≥38%). To require a 15% annual return, it would need to be bought at ~$160.

Thesis

The business

Salesforce is the leader in customer relationship management software, a recurring-subscription business (95% of revenue) with a wide switching-cost moat, sharply expanding margins (non-GAAP operating margin 22.5%→34.1% over 4 years, with ValueAct's activism pushing the discipline) and a $72.4bn contracted backlog that anticipates revenue. It is a quality SaaS: capital-light, large and predictable cash flow, high stickiness. The open question is the direction of the moat in the face of AI.

The valuation

A quality SaaS is valued on EV/owner-FCF net of stock-based compensation (§3: reported cash flow adds that cost back, ~24% of the flow — it must be expensed). TTM owner-FCF is ~$11.1bn (free cash flow $14.7bn − stock-based compensation $3.6bn). With the ASR net debt (~$27.9bn) in the bridge, EV/owner-FCF is ~19× — the cheap end of quality software (the band is 14-20×). The 'P/FCF' shown by aggregators is doubly misleading: it adds back stock-based compensation and the price ignores net debt.

The base scenario projects owner-FCF growing ~8%/year (revenue ~8% organic + margin expansion) from ~$11bn to ~$16.4bn over five years, at an exit multiple of 15× (no re-rating — it is already at a depressed multiple). With the buyback reducing shares ~1.5%/year, that yields ~$308/share → a total return of +6%/year. Leverage amplifies: as the flow grows, equity grows faster than enterprise value.

The margin of safety

It trades close to intrinsic value, far from the required margin of safety. At ~$234, the market is paying for Salesforce as if it were a mature, no-growth SaaS doomed by AI. The base scenario ($308/share over five years) implies a total return of +6%/year — above the required return floor: the verdict is Fairly valued. The discrepancy between perception and reality is the source of the opportunity: the moat (switching costs + a $72bn contracted backlog) and the compounding cash flow are undervalued because reported growth looks confusing (two taxonomy redesigns in 6 months + the noise from Informatica) and because the fear of AI disruption is fully priced in. The risk is real and defines the adverse scenario: if AI cannibalizes seats and organic growth stalls, with the new leverage the value falls below the price. It is an asymmetry with wide upside and a bounded — but material — downside.

What to watch

Three things. AI disruption: if Agentforce monetizes agent work (its ARR already crossed $1.2bn, +205%) and offsets the pressure on seats, the thesis is confirmed; if seats erode without AI consumption replacing them, the moat narrows — this is the central disconfirmer. Organic reacceleration: the company guides for it in the second half of FY27; if reported growth keeps leaning on Informatica (~3pp) without the organic figure picking up, the quality of growth disappoints. And the balance sheet: the new leverage ($39bn of debt) cut the flow guidance — watch that deleveraging and the buyback don't compete with reinvestment. If organic growth stabilizes and Agentforce scales, the current discount closes; if AI bites into seats before Agentforce offsets it, the leverage hurts.

Educational / informational. Does not constitute investment advice.

Other companies of the same type